4.5 Review

Antimicrobial peptides (AMPs): a patent review (2015-2020)

期刊

EXPERT OPINION ON THERAPEUTIC PATENTS
卷 30, 期 12, 页码 931-947

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/13543776.2020.1851679

关键词

Antimicrobial drugs; antimicrobial resistance; antimicrobial peptides; ESKAPE

向作者/读者索取更多资源

Introduction: Antimicrobial peptides are a large class of compounds that are part of innate immune response found among all classes of life and are considered promising compounds to deal with antimicrobial resistance. These AMPs have been demonstrated to have some advantages over the traditional antibiotics with a broad spectrum of antimicrobial activities and even overcome bacterial drug-resistance. Areas covered: The present review represents a comprehensive analysis of patents and patent applications available on Espacenet, from the year 2015 to 2020 referring to the therapeutic use of AMPs. Expert opinion: There are important examples about the use of antimicrobial peptides in clinical practice (e.g. polimixin b, colistin, etc.). AMPs are usually inspired by nature being produced by different living organisms as defensive and/or competition mechanisms. Despite limitations related to their development in classical drug discovery pipeline, they are endowed with relevant advantages, such as an unlimited reservoir of organisms able to produce new AMPs and they represent good starting point upon which to develop new antimicrobials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Aspergillus fumigatus tryptophan metabolic route differently affects host immunity

Teresa Zelante, Tsokyi Choera, Anne Beauvais, Francesca Fallarino, Giuseppe Paolicelli, Giuseppe Pieraccini, Marco Pieroni, Claudia Galosi, Claudia Beato, Antonella De Luca, Francesca Boscaro, Riccardo Romoli, Xin Liu, Adilia Warris, Paul E. Verweij, Eloise Ballard, Monica Borghi, Marilena Pariano, Gabriele Costantino, Mario Calvitti, Carmine Vacca, Vasilis Oikonomou, Marco Gargaro, Alicia Yoke Wei Wong, Louis Boon, Marcel den Hartog, Zdenek Spacil, Paolo Puccetti, Jean-Paul Latge, Nancy P. Keller, Luigina Romani

Summary: Research shows that Aspergillus fumigatus expresses different ido genes under varying environmental conditions, and loss of these genes results in increased pathogenicity and inflammation. Fungal tryptophan metabolic pathways cooperate with the host xenobiotic response to shape host-microbe interactions.

CELL REPORTS (2021)

Article Chemistry, Medicinal

Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant

Giannamaria Annunziato, Costanza Spadini, Nina Franko, Paola Storici, Nicola Demitri, Marco Pieroni, Sara Flisi, Lucrezia Rosati, Mattia Iannarelli, Marialaura Marchetti, Joana Magalhaes, Stefano Bettati, Andrea Mozzarelli, Clotilde Silvia Cabassi, Barbara Campanini, Gabriele Costantino

Summary: This study demonstrates the use of an OASS inhibitor as a colistin adjuvant to treat infections caused by Gram-positive and Gram-negative pathogens, showing promising synergistic or additive activities. The compound binds OASS, engages the intracellular target, has good safety profile, and its 3D structure complexed with OASS is determined by crystallography, providing insights for further research on developing a new class of adjuvants.

ACS INFECTIOUS DISEASES (2021)

Article Chemistry, Medicinal

Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants

Joana Magalhaes, Nina Franko, Samanta Raboni, Giannamaria Annunziato, Paivi Tammela, Agostino Bruno, Stefano Bettati, Stefano Armao, Costanza Spadini, Clotilde Silvia Cabassi, Andrea Mozzarelli, Marco Pieroni, Barbara Campanini, Gabriele Costantino

Summary: Many bacteria and actinomycetales use L-cysteine biosynthesis to increase their tolerance to antibacterial treatment, leading to the onset of antimicrobial resistance, which is a serious threat to public health worldwide. In this study, a series of inhibitors targeting Salmonella thyphimurium serine acetyltransferase (SAT) were developed, showing promising potential, although the most potent compound failed to inhibit bacterial growth in experiments, indicating the need for further research.

PHARMACEUTICALS (2021)

Article Pharmacology & Pharmacy

Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction

Michele Biagioli, Silvia Marchiano, Rosalinda Roselli, Cristina Di Giorgio, Rachele Bellini, Martina Bordoni, Anna Gidari, Samuele Sabbatini, Daniela Francisci, Bianca Fiorillo, Bruno Catalanotti, Eleonora Distrutti, Adriana Carino, Angela Zampella, Gabriele Costantino, Stefano Fiorucci

Summary: The study found that pelargonidin can reverse intestinal inflammation by activating the Aryl hydrocarbon Receptor, reducing ACE2 induction. This has potential implications for combating SARS-CoV-2.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Inhibition studies of bacterial α-carbonic anhydrases with phenols

Simone Giovannuzzi, Chad S. Hewitt, Alessio Nocentini, Clemente Capasso, Gabriele Costantino, Daniel P. Flaherty, Claudiu T. Supuran

Summary: The inhibition of alpha-class carbonic anhydrases (CAs) from bacterial pathogens by phenols and phenolic acids was investigated. Small changes in the phenol scaffold led to drastic effects on the inhibitory activity of bacterial CA. This underinvestigated class of bacterial CA inhibitors may have potential in fighting drug resistant bacteria.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

Amine- and Amino Acid-Based Compounds as Carbonic Anhydrase Activators

Andrea Angeli, Emanuela Berrino, Simone Carradori, Claudiu T. Supuran, Marzia Cirri, Fabrizio Carta, Gabriele Costantino

Summary: After being neglected in the past, carbonic anhydrase activators (CAAs) have been proven to be useful in pharmaceutical and industrial applications, with amino acid and amine derivatives being the most explored compounds.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

Benzoselenoates: A novel class of carbonic anhydrase inhibitors

Damiano Tanini, Antonella Capperucci, Maria Locuoco, Marta Ferraroni, Gabriele Costantino, Andrea Angeli, Claudiu T. Supuran

Summary: A series of benzoselenoates were prepared and investigated for their inhibitory properties against various human Carbonic Anhydrases isoforms. The study revealed that benzoselenoates may serve as potential new inhibitors with higher selectivity and efficacy for different hCAs.

BIOORGANIC CHEMISTRY (2022)

Article Chemistry, Medicinal

Selenocarbamates As a Prodrug-Based Approach to Carbonic Anhydrase Inhibition

Andrea Angeli, Marta Ferraroni, Antonella Capperucci, Damiano Tanini, Gabriele Costantino, Claudiu T. Supuran

Summary: This study presents the activity of selenocarbamates as novel carbonic anhydrase (CA) inhibitors. Through CA-mediated hydrolysis, selenocarbamates release selenolates that effectively inhibit CA by binding to zinc. Different human CA isoforms were evaluated against a series of selenocarbamates with high molecular diversity and complexity. X-ray studies provided insights into the binding mode of this novel class of CA inhibitors.

CHEMMEDCHEM (2022)

Article Biochemistry & Molecular Biology

Development of Praziquantel sulphonamide derivatives as antischistosomal drugs

Andrea Angeli, Marta Ferraroni, Fabrizio Carta, Cecile Haeberli, Jennifer Keiser, Gabriele Costantino, Claudiu T. Supuran

Summary: The limited options for treating schistosomiasis necessitate the discovery of alternative drugs. This study successfully inhibited the growth of Schistosoma mansoni using new PZQ derivatives, but further optimization is still needed.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1

Silvia Grottelli, Giannamaria Annunziato, Gioena Pampalone, Marco Pieroni, Mirco Dindo, Francesca Ferlenghi, Gabriele Costantino, Barbara Cellini

Summary: This study aimed to find pharmacological chaperones for the treatment of primary hyperoxaluria type I (PH1). The researchers screened and chemically optimized compounds, identifying a promising hit compound and drawing conclusions about the requirements for optimal pharmacological chaperone activity.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

The Prognostic Value of Derivatives-Reactive Oxygen Metabolites (d-ROMs) for Cardiovascular Disease Events and Mortality: A Review

Filippo Pigazzani, Davide Gorni, Kenneth A. Dyar, Matteo Pedrelli, Gwen Kennedy, Gabriele Costantino, Agostino Bruno, Isla Mackenzie, Thomas M. MacDonald, Uwe J. F. Tietge, Jacob George

Summary: Oxidative stress plays a role in the development and exacerbation of cardiovascular diseases. Derivatives-reactive oxygen metabolites (d-ROMs) are a new biomarker of oxidative stress that can be quantified within minutes. High levels of d-ROMs are an independent predictor of cardiovascular events and mortality, while low levels of d-ROMs are a good negative predictor for cardiovascular events in patients with coronary artery disease and heart failure. Combining d-ROMs with other commonly used biomarkers may help in more accurate cardiovascular risk assessment.

ANTIOXIDANTS (2022)

Article Chemistry, Medicinal

Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria

Giannamaria Annunziato, Costanza Spadini, Marialaura Marchetti, Nina Franko, Marialaura Pavone, Mattia Iannarelli, Agostino Bruno, Marco Pieroni, Stefano Bettati, Clotilde Silvia Cabassi, Barbara Campanini, Gabriele Costantino

Summary: Antibacterial adjuvants are important for reducing therapeutic dose and antibacterial resistance. OASS inhibitors were found to be potential colistin adjuvants for treating infections caused by critical pathogens. Derivatives of OASS inhibitors showed good activity and low toxicity in vitro, and exhibited additive or synergistic effects against pathogenic bacteria in vitro. The engagement of OASS inside bacteria cells was confirmed.

PHARMACEUTICALS (2022)

Article Chemistry, Medicinal

New β-arylchalcogeno amines with procognitive properties targeting Carbonic Anhydrases and Monoamine Oxidases

Gustavo Provensi, Alessia Costa, Barbara Rani, Maria Vittoria Becagli, Fabio Vaiano, Maria Beatrice Passani, Damiano Tanini, Antonella Capperucci, Simone Carradori, Jacobus P. Petzer, Anel Petzer, Daniela Vullo, Gabriele Costantino, Patrizio Blandina, Andrea Angeli, Claudiu T. Supuran

Summary: This study reported the synthesis of β-arylchalcogeno amines with structural similarity to amphetamine, which showed good activation properties for certain enzymes in the brain. In vivo evaluation demonstrated the procognitive effects of these compounds without causing unwanted side effects. These findings suggest the potential utility of these compounds for improving cognitive decline associated with neurodegenerative and psychiatric diseases.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl) isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization

Miriam Girardini, Francesca Ferlenghi, Giannamaria Annunziato, Giulia Degiacomi, Bianca Papotti, Cinzia Marchi, Jose Camilla Sammartino, Sari S. Rasheed, Anna Contini, Maria Rosalia Pasca, Federica Vacondio, Joanna C. Evans, Thomas Dick, Rolf Mueller, Gabriele Costantino, Marco Pieroni

Summary: Tuberculosis is a deadly infectious disease and the increase in drug-resistant strains is concerning. Previous studies have identified compounds with inhibitory activity against Mycobacterium tuberculosis strains. In this study, researchers aimed to determine the metabolic fate of these compounds and explore structural modifications to improve activity and avoid rapid clearance. Novel antitubercular chemotypes were also investigated. The findings led to the design of improved compounds with good activity against drug-susceptible and drug-resistant strains.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties

Marialaura Pavone, Samanta Raboni, Marialaura Marchetti, Giannamaria Annunziato, Stefano Bettati, Bianca Papotti, Cinzia Marchi, Emanuele Carosati, Marco Pieroni, Barbara Campanini, Gabriele Costantino

Summary: The development of antibiotic adjuvants as inhibitors of non-essential targets is an innovative approach to combat antimicrobial resistance. This study focuses on compounds targeting serine acetyltransferase (SAT), a key enzyme involved in cysteine biosynthesis. A new compound with promising SAT inhibitory activity has been discovered, and further investigation into its potential and structure-activity relationships has been conducted.

RESULTS IN CHEMISTRY (2022)

暂无数据